Mielóma multiplex: vizsgálatok itt: Dél-Korea
35 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 3. fázisFut, nem toborozA Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
- Where
- Busan, Daegu, Hwasun-gun, Incheon, Seongnam-si, Seoul
- Életkor
- 18 év and over
- People
- 893 worldwide
- Run by
- Pfizer
See details and how to joinNCT05020236 · EU 2023-509208-14-00 - 1/2. fázisTaking peopleA Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
- Where
- Seoul
- Életkor
- 18 év and over
- People
- 123 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT05714839 · EU 2022-501941-63-00 - 1/2. fázisTaking peopleA Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)
- Where
- Seoul
- Életkor
- 18 év and over
- People
- 220 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT06292780 · EU 2023-507809-34-00 - 3. fázisNot yet taking people in Dél-KoreaStudy of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
- Where
- Seoul
- Életkor
- 18 év and over
- People
- 750 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07764978 - 3. fázisTaking peopleA Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
- Where
- Hwasun, Jeonju, Seoul, Ulsan
- Életkor
- 18 év and over
- People
- 520 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT06679101 · EU 2024-516030-35-00 - 1/2. fázisTaking peopleA Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- Where
- Hwasun, Seoul
- Életkor
- 12 év and over
- People
- 606 worldwide
- Run by
- Sumitomo Pharma America, Inc.
See details and how to joinNCT04988555 - No phaseNot yet taking people in Dél-KoreaExploring the Effects of Korean-Style Mediterranean Diet (KORMED) and Physical Activity Measurement in Patients With MGUS/SMM: A Pilot Study
- Where
- Seongnam-si
- Életkor
- 19 év to 80 év
- People
- 20
- Run by
- Seoul National University Bundang Hospital
See details and how to joinNCT07305662 - 1/2. fázisTaking peopleMezigdomide and Elranatamab for Relapsed and/or Refractory Multiple Myeloma
- Where
- Hwasun, Seoul
- Életkor
- 19 év and over
- People
- 75 worldwide
- Run by
- YOUNGIL KOH
See details and how to joinNCT06645678 - 2. fázisTaking peoplePhase II Trials of Letermovir Prophylaxis in Patients With RRMM Undergoing Elranatamab Therapy
- Where
- Seoul
- Életkor
- 19 év and over
- People
- 40
- Run by
- Seoul National University Hospital
See details and how to joinNCT06920251 - No phaseTaking peopleQuality of Life and Treatment Outcomes in RRMM Patients Receiving Advanced vs. Conventional Immunotherapies
- Where
- Seocho
- Életkor
- 19 év and over
- People
- 174
- Run by
- Sung-Soo Park
See details and how to joinNCT07051850